Table 2.
Peri-transplant Patient Characteristics and Outcomes Stratified by Blood Glucose Level
| Mean Glucose < 200 mg/dL n=114 N (%) or mean± SD |
Mean Glucose > 200 mg/dL n=30 N (%) or mean± SD |
Total n=144 N (%) or mean± SD |
p value | |
|---|---|---|---|---|
| Age | 53.7 ± 10.7 | 54.5 ± 12.5 | 53.9 ± 11.1 | p = ns |
| Gender (% female) | 37 (32.5) | 11 (36.7) | 46 (31.9) | p = ns |
| MELD score | 20.7 ± 9.8 | 20.6 ± 10.3 | 20.7 ± 9.8 | p = ns |
| Liver-Kidney Transplant | 26 (22.8) | 5 (16.7) | 31 (21.5) | p = ns |
| On Insulin Drip | 53 (46.5) | 20 (66.7) | 73 (50.6) | p = ns |
| Average Blood Glucose (Pre Liver Transplant) |
117.9 ± 35.4 | 156.6 ± 59.8 | 129.1 ± 43.9 | p < 0.001 |
| Average Blood Glucose (Post Liver Transplant) |
154.9 ± 22.3 | 232.8 ± 21.4 | 159.1 ± 31.8 | p < 0.001 |
| Diabetic Status | 32 (28%) | 18 (60%) | 50 (35) | p = 0.002 |
| Rejection | 40 (35.1) | 23 (76.7) | 63 (43.8) | p <0.001 |
| Re-Hospitalization | 71 (62.3) | 21 (70.0) | 92 (63.8) | p = ns |
| Infection | 68 (59.6) | 16 (53.3) | 84 (58.3) | p = ns |
| Graft survival | 98 (86.0) | 28 (93.3) | 126 (87.5) | p = ns |
| Patient Survival | 108 (94.7) | 28 (93.3) | 136 (94.4) | p = ns |
| Prolonged ventilation | 37 (32.5) | 4 (13.3) | 41 (28.5) | p = 0.047 |
| Average Prednisone Dose (mg/d) |
184.4 + 146.4 | 237.8 + 140.5 | 195.5 +146.0 | p=ns |
| Proportion using Tacrolimus (%) |
95.6% | 100% | 96.5% | p=ns |
| Tacrolimus Average Levels |
8.51 + 3.82 | 9.55 + 5.38 | 8.74 + 4.62 | p=ns |
MELD – Model of End-Stage Liver Disease